CGTX Stock Analysis: Buy, Sell, or Hold?
CGTX - Cognition Therapeutics, Inc. Common Stock
$1.27
0.06 (4.98%)
▲
5d:
+4.98%
30d:
+5.86%
90d:
+17.62%
BUY
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When CGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CGTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CGTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CGTX is currently trading at $1.27, which is considered slightly high relative to its 30-day fair value range of $1.14 to $1.29.
Technical Outlook: Technically, CGTX is in a strong uptrend. Immediate support is located at $1.12, while resistance sits at $1.50. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.50 (+189.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGTX is in a strong uptrend. Immediate support is located at $1.12, while resistance sits at $1.50. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.50 (+189.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.14 -
$1.29
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 189.3% below Wall St target ($3.50)
Trading Range Analysis
30-Day Trading Range
$1.14 -
$1.29
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.12
Resistance Level
$1.50
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.37
Wall Street Target
$3.50
(+189.3%)
Share & Embed Analysis
Last updated: June 15, 2026 11:06 AM ET
Data refreshes hourly during market hours. Next update: 12:06 PM
Data refreshes hourly during market hours. Next update: 12:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGTX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John Brendan Doyle
BUY
10000 shares
2026-04-16
Lisa Ricciardi
BUY
9175 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 60 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
